Epigenetic changes in the CDKN2A locus are associated with differential expression of P16INK4A and P14ARF in HPV-positive oropharyngeal squamous cell carcinoma

Cancer Medicine

Volumn 4, Issue 3, 2015, Pages 342-353

  Schlecht, Nicolas F ^a   Ben Dayan, Miriam ^a   Anayannis, Nicole ^a   Lleras, Roberto A ^a   Thomas, Carlos ^a   Wang, Yanhua ^a   Smith, Richard V ^a,b   Burk, Robert D ^a   Harris, Thomas M ^a   Childs, Geoffrey ^a   Ow, Thomas J ^a,b   Prystowsky, Michael B ^a   Belbin, Thomas J ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

Carcinoma; HPV; Methylation; Oropharynx; Squamous

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; PROTEIN P14; PROTEIN P16; MESSENGER RNA;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; EPIGENETICS; FEMALE; GENE EXPRESSION; GENE LOCUS; GENETIC ASSOCIATION; HUMAN; MALE; OROPHARYNGEAL SQUAMOUS CELL CARCINOMA; OROPHARYNX CARCINOMA; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TRANSCRIPTION INITIATION SITE; WART VIRUS; GENETIC EPIGENESIS; GENETICS; METABOLISM; MIDDLE AGED; OROPHARYNX TUMOR; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CPG ISLANDS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; HUMANS; MALE; MIDDLE AGED; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEIN P14ARF;

EID: 84979857786     PISSN: None     EISSN: 20457634     Source Type: Journal    
DOI: 10.1002/cam4.374     Document Type: Article

References (28)

1. Ang, K. K., J. Harris, R. Wheeler, R. Weber, D. I. Rosenthal, P. F. Nguyen-Tan, et al. 2010. Human papillomavirus and survival of patients with oropharyngeal cancer. N. Engl. J. Med. 363:24-35.
2. O'Regan, E. M., M. E. Toner, S. P. Finn, C. Y. Fan, M. Ring, B. Hagmar, et al. 2008. p16(INK4A) genetic and epigenetic profiles differ in relation to age and site in head and neck squamous cell carcinomas. Hum. Pathol. 39:452-458.
3. Richards, K. L., B. Zhang, K. A. Baggerly, S. Colella, J. C. Lang, D. E. Schuller, et al. 2009. Genome-wide hypomethylation in head and neck cancer is more pronounced in HPV-negative tumors and is associated with genomic instability. PLoS ONE 4:e4941.
4. Hafkamp, H. C., E. J. Speel, A. Haesevoets, F. J. Bot, W. N. Dinjens, F. C. Ramaekers, et al. 2003. A subset of head and neck squamous cell carcinomas exhibits integration of HPV 16/18 DNA and overexpression of p16INK4A and p53 in the absence of mutations in p53 exons 5-8. Int. J. Cancer 107:394-400.
5. Farthing, A. J., and K. H. Vousden . 1994. Functions of human papillomavirus E6 and E7 oncoproteins. Trends Microbiol. 2:170-174.
6. Fischer, C. A., I. Zlobec, E. Green, S. Probst, C. Storck, A. Lugli, et al. 2010. Is the improved prognosis of p16 positive oropharyngeal squamous cell carcinoma dependent of the treatment modality? Int. J. Cancer 126:1256-1262.
7. Schlecht, N. F., M. Brandwein-Gensler, G. J. Nuovo, M. Li, A. Dunne, N. Kawachi, et al. 2011. A comparison of clinically utilized human papillomavirus detection methods in head and neck cancer. Mod. Pathol. 24:1295-1305.
8. Salazar, C. R., N. Anayannis, R. V. Smith, Y. Wang, B. A. Schiff, M. Haigentz, et al. 2014. Combined p16 and HPV expression predicts head and neck cancer survival. Int. J. Cancer. 135:2404?2412.
9. Steinmann, K., A. Sandner, U. Schagdarsurengin, and R. H. Dammann . 2009. Frequent promoter hypermethylation of tumor-related genes in head and neck squamous cell carcinoma. Oncol. Rep. 22:1519-1526.
10. Worsham, M. J., J. K. Stephen, K. M. Chen, S. Havard, V. Shah, G. Gardner, et al. 2014. Delineating an epigenetic continuum in head and neck cancer. Cancer Lett. 342:178-184.
11. Lleras, R., R. V. Smith, L. R. Adrien, N. F. Schlecht, R. D. Burk, T. Harris, et al. 2013. Unique DNA methylation loci distinguish anatomic site and HPV status in head and neck squamous cell carcinoma. Clin. Cancer Res. 19:5444-5455.
12. Braakhuis, B. J., P. J. Snijders, W. J. Keune, C. J. Meijer, H. J. Ruijter-Schippers, C. R. Leemans, et al. 2004. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus. J. Natl. Cancer Inst. 96:998-1006.
13. Mancuso, F. M., M. Montfort, A. Carreras, A. Alibes, and G. Roma . 2011. HumMeth27QCReport: an R package for quality control and primary analysis of Illumina Infinium methylation data. BMC Res. Notes 4:546.
14. Eisen, M. B., P. T. Spellman, P. O. Brown, and D. Botstein . 1998. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA 95:14863-14868.
15. 2012. Comprehensive genomic characterization of squamous cell lung cancers. Nature 489:519-525.
16. van Kempen, P. M., R. Noorlag, W. W. Braunius, I. Stegeman, S. M. Willems, and W. Grolman . 2014. Differences in methylation profiles between HPV-positive and HPV-negative oropharynx squamous cell carcinoma: a systematic review. Epigenetics 9:194-203.
17. Kostareli, E., D. Holzinger, O. Bogatyrova, T. Hielscher, G. Wichmann, M. Keck, et al. 2013. HPV-related methylation signature predicts survival in oropharyngeal squamous cell carcinomas. J. Clin. Invest. 123:2488-2501.
18. Lechner, M., T. Fenton, J. West, G. Wilson, A. Feber, S. Henderson, et al. 2013. Identification and functional validation of HPV-mediated hypermethylation in head and neck squamous cell carcinoma. Genome Med. 5:15.
19. Wentzensen, N., M. E. Sherman, M. Schiffman, and S. S. Wang . 2009. Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science. Gynecol. Oncol. 112:293-299.
20. Paz, M. F., M. F. Fraga, S. Avila, M. Guo, M. Pollan, J. G. Herman, et al. 2003. A systematic profile of DNA methylation in human cancer cell lines. Cancer Res. 63:1114-1121.
21. Sartor, M. A., D. C. Dolinoy, T. R. Jones, J. A. Colacino, M. E. Prince, T. E. Carey, et al. 2011. Genome-wide methylation and expression differences in HPV(+) and HPV(-) squamous cell carcinoma cell lines are consistent with divergent mechanisms of carcinogenesis. Epigenetics 6:777-787.
22. Paschos, K., and M. J. Allday . 2010. Epigenetic reprogramming of host genes in viral and microbial pathogenesis. Trends Microbiol. 18:439-447.
23. Boyer, S. N., D. E. Wazer, and V. Band . 1996. E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res. 56:4620-4624.
24. Elliott, M. J., Y. B. Dong, H. Yang, and K. M. McMasters . 2001. E2F-1 up-regulates c-Myc and p14(ARF) and induces apoptosis in colon cancer cells. Clin. Cancer Res. 7:3590-3597.
25. Zeng, Y., Y. Kotake, X. H. Pei, M. D. Smith, and Y. Xiong . 2011. p53 binds to and is required for the repression of Arf tumor suppressor by HDAC and polycomb. Cancer Res. 71:2781-2792.
26. Scheffner, M., B. A. Werness, J. M. Huibregtse, A. J. Levine, and P. M. Howley . 1990. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63:1129-1136.
27. Medvedeva, Y. A., M. V. Fridman, N. J. Oparina, D. B. Malko, E. O. Ermakova, I. V. Kulakovskiy, et al. 2010. Intergenic, gene terminal, and intragenic CpG islands in the human genome. BMC Genom. 11:48.
28. Peralta-Zaragoza, O., V. Bermudez-Morales, L. Gutierrez-Xicotencatl, J. Alcocer-Gonzalez, F. Recillas-Targa, and V. Madrid-Marina . 2006. E6 and E7 oncoproteins from human papillomavirus type 16 induce activation of human transforming growth factor beta1 promoter throughout Sp1 recognition sequence. Viral Immunol. 19:468-480.